Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Transmission and prevention news

Show

From To
HIV treatment finally has a game-changer, and it’s called Truvada

The widely reported Proud study shows just how effective pre-exposure prophylaxis (PrEP) can be at preventing HIV transmission. PrEP is, quite simply, a game-changer and represents a wake-up call for the government, NHS England and local authorities to make PrEP a key component in our strategy to defeat HIV.

Published
26 February 2015
From
The Guardian
Combining PrEP and ART could almost eliminate HIV infection, east African study finds

Giving both pre-exposure prophylaxis (PrEP) and antiretroviral therapy (ART) to heterosexual couples where one partner has HIV (serodiscordant couples) can almost eliminate the chance of infection in the

Published
26 February 2015
By
Gus Cairns
PrEP use rising in San Francisco, but scaling up could further cut new infections

Use of Truvada (tenofovir/emtricitabine) pre-exposure prophylaxis, better known as PrEP, is increasing in San Francisco, but it is still only reaching about one-third of people who could benefit,

Published
25 February 2015
By
Liz Highleyman
CDC Statement on IPERGAY Trial of Pre-Exposure Prophylaxis (PrEP) for HIV Prevention among Men Who Have Sex with Men

The US Centers for Disease Control (CDC) today welcomed the news of the successful findings of the PROUD and Ipergay studies but expressed caution on interpreting Ipergay's results. CDC's director of HIV/AIDS, Viral Hepatitis, STD & TB prevention said: "Since available data suggest that men in this study were taking PrEP an average of three to four days per week, CDC cautions that researchers do not yet know if this regimen will work among MSM who have sex less frequently and would therefore be taking PrEP less often." The CDC , he added, "continues to recommend only daily use of PrEP, as approved by the FDA." However he noted that "the IPERGAY findings combined with other recent research suggests that even with less than perfect daily adherence, PrEP may still offer substantial protection if taken consistently."

Published
25 February 2015
From
CDC (US)
HIV and LGTB NGOs and other concerned actors across Europe call for futher action on pre-exposure prophylaxis

The European AIDS Treatment Group (EATG), Europe’s network of HIV activists, and  AIDES, a leading French NGO in the fight against AIDS and viral hepatitis, backed by 81 European HIV LGBT civil society organisations and concerned actors, issued an urgent HIV Prevention Manifesto today. We demand that pre-exposure prophylaxis for HIV (PrEP) is made available as soon as possible within the European Union, and that Gilead, the company that makes the PrEP medicine Truvada®, submits an application to the European Medicines Agency (EMA) for a change of indication so that its use to prevent HIV can be approved.

Published
25 February 2015
From
EATG
Disappointing result for tenofovir-gel microbicide shows that young women still lack HIV prevention methods they can use

Among some highly promising results from HIV prevention studies presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2015) in Seattle, USA, today, there was

Published
25 February 2015
By
Gus Cairns
'Give HIV drugs to healthy gay men'

Healthy gay men should be offered daily HIV drugs to prevent infections, say UK Medical Research Council and Public Health England scientists. Their study, on 545 high-risk men, found one case of HIV could be stopped for every 13 men treated for a year. The research team says it would be similar to the pill for women and would not encourage risky sex. The findings have been described as a "game changer" and the NHS is considering how to adopt them.

Published
25 February 2015
From
BBC News
Pre-exposure prophylaxis also stops 86% of HIV infections in Ipergay study

A French and Canadian study of pre-exposure prophylaxis (PrEP) presented today at the Conference on Retroviruses and Opportunistic Infections (CROI 2015) in Seattle, USA, found that

Published
24 February 2015
By
Gus Cairns
Pre-exposure prophylaxis (PrEP) stops 86% of HIV infections in PROUD study

A study of pre-exposure prophylaxis (PrEP), the English PROUD study, demonstrated the highest effectiveness yet seen for this method of HIV prevention, the Conference on Retroviruses and

Published
24 February 2015
By
Gus Cairns
Local spending on HIV prevention in England plunges to 70p per person, per year

HIV prevention in England is underfunded and deprioritised, says the National AIDS Trust (NAT). Whereas £55 million was allocated to local activities in 2001-02, the figure for

Published
24 February 2015
By
Roger Pebody

Filter by country